患有沃尔登斯特罗姆巨球蛋白血症的患者有血小板和凝血功能受损
Simone A Brysland1, Dipti Talaulikar2,3, Sarah M Hicks1
1Division of Genome Science and Cancer, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Blood advances
|August 29, 2024
概括
沃尔登斯特罗姆巨球蛋白血症 (WM) 患者由于血小板功能和凝血异常而表现出血液静止功能受损. 它们的免疫球蛋白M (IgM) 也阻碍了体外血液凝固,影响了整体血液静止.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 血液静止和血栓形成
背景情况:
- 沃尔登斯特罗姆巨型球蛋白血症 (WM) 是一种与出血风险相关的B细胞淋巴瘤,部分原因是布鲁顿的氨酸激酶抑制剂 (BTKis) 等疗法.
- 以前的研究还没有完全研究WM患者的静血功能障碍,特别是有关血小板功能,凝血和血管完整性的研究.
研究的目的:
- 为了评估沃尔登斯特罗姆巨型球蛋白血症患者的静血功能障碍.
- 评估WM衍生的免疫球蛋白M (IgM) 在体外血静的影响.
主要方法:
- 从WM患者 (开启/关闭BTKis) 和健康捐赠者 (HDs) 收集的全血 (WB) 样本.
- 评估了血小板功能 (受体水平,网化,扩散,聚合),血血栓生成和WB凝结潜力.
- 使用ELISA测量了可溶性血糖蛋白VI (sGPVI) 和血清血栓形成素 (TPO).
主要成果:
- 脑膜炎患者的血小板收缩减少,血清TPO水平增加.
- 在WM血中,血栓生成速度较慢,而WM血小板对内源性血栓潜能 (ETP) 的贡献较小.
- 在体外,WM衍生的IgM显著损害了HD样本中的血小板扩散,聚合和ETP.
结论:
- 患有沃尔登斯特罗姆巨球蛋白血症的患者表现出血栓潜力和WB凝固的显著变化.
- 在体外,WM衍生的IgM显然会损害血液静止.
- 瓦尔登斯特罗姆巨型球蛋白血症患者的血小板和凝固特性受到干扰,即使管理良好.
相关概念视频
01:18Structure and Function of Platelets
1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
01:24Disorders of Hemostasis
754
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
754
01:22Formation of the Platelet Plug
5.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654